Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
US7449447B2 · kind B2 · utility
7Cited by
1References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2004 |
| Grant date | Nov 11, 2008 |
| Priority date | — |
| Expiry date | Dec 30, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said compound, or of said prodrug, said compound having the general structure shown in Formula 1:useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.